At the product launch event held aboard a cruise in Xiamen, the whole blood chemiluminescence C2100, together with the LAS-H2 automation line, delivers a powerful dual-engine solution. Breakthrough innovations—including the small-molecule sandwich assay and the fatty liver panel—demonstrate strong technological excellence. Driven by innovation, Hotgen is reinforcing its national liver health initiative, building a comprehensive diagnostic portfolio for liver specialty diseases, and shaping a new blueprint that spans the full cycle of “diagnosis, management, and prevention.”
This is the first one.
English
français
Deutsch
Español
ไทย
русский
português
العربية
Indonesia